The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 13, 2023
Filed:
Apr. 20, 2018
Applicant:
Epizyme, Inc., Cambridge, MA (US);
Inventors:
John Emmerson Campbell, Cambridge, MA (US);
Kenneth William Duncan, Westwood, MA (US);
Maria Alejandra Raimondi, Jamaica Plain, MA (US);
Christine Klaus, Waban, MA (US);
Elayne Penebre, Auburndale, MA (US);
Assignee:
Epizyme, Inc., Cambridge, MA (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/505 (2006.01); A61K 31/506 (2006.01); A61P 35/00 (2006.01); A61K 31/203 (2006.01); A61K 31/4375 (2006.01); A61K 31/44 (2006.01); A61K 31/496 (2006.01); A61K 31/517 (2006.01); A61K 31/519 (2006.01); A61K 31/706 (2006.01);
U.S. Cl.
CPC ...
A61K 31/506 (2013.01); A61K 31/203 (2013.01); A61K 31/4375 (2013.01); A61K 31/44 (2013.01); A61K 31/496 (2013.01); A61K 31/517 (2013.01); A61K 31/519 (2013.01); A61K 31/706 (2013.01); A61P 35/00 (2018.01);
Abstract
The present disclosure relates to a method of preventing or treating a cancer via administering an EHMT2 inhibitor or a combination comprising an EHMT2 inhibitor compound and one or more additional therapeutic agent disclosed herein or a pharmaceutical composition thereof to subjects in need thereof. The present disclosure also relates to the use of such compounds or combinations for research or other non-therapeutic purposes.